CEO: Paul Grayson.

Financial information: $38 million in venture capital to date, including a $25 million Series A round in 2009.

No. of local employees: 28.

Investors: 5AM Ventures, Apposite Capital LLP, Aravis SA, Merck Serono Ventures, SR One, and Versant Ventures.

Headquarters: Torrey Pines.

Year founded: 2007.

Company description: Anaphore is pursuing a new class of protein pharmaceuticals that target various cancers and autoimmune disorders, as well as other diseases.

Key factors for success: Anaphore is moving in a new direction with its treatment platform that promises to take biologics to a higher level in treating difficult to treat diseases.

The appointment of veteran life sciences executive Paul Grayson as the new president and CEO of Anaphore Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129